Forma

Forma is where molecules become medicine. Formed in 2026 as a next-generation CDMO, we offer formulation development and manufacturing for oral solid dosage programs from early clinical development through commercial manufacturing. Our capabilities are grounded in nearly 30 years of formulation expertise, including deep experience in amorphous solid dispersion and modified release technologies, developed through long-standing operations in Southern California.